Wendell David Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Sell |
2,087
-370
| -15% | -$178K | 0.11% | 91 |
|
|
2026
Q1 | $1.21M | Sell |
2,457
-5
| -0.2% | -$2.71K | 0.13% | 84 |
|
|
2025
Q4 | $1.43M | Sell |
2,462
-115
| -4% | -$65K | 0.15% | 78 |
|
|
2025
Q3 | $1.25M | Sell |
2,577
-104
| -4% | -$48.4K | 0.12% | 82 |
|
|
2025
Q2 | $1.09M | Sell |
2,681
-278
| -9% | -$116K | 0.11% | 88 |
|
|
2025
Q1 | $1.47M | Sell |
2,959
-1,247
| -30% | -$675K | 0.15% | 77 |
|
|
2024
Q4 | $2.19M | Sell |
4,206
-90
| -2% | -$49.5K | 0.22% | 68 |
|
|
2024
Q3 | $2.66M | Buy |
4,296
+176
| +4% | +$104K | 0.25% | 64 |
|
|
2024
Q2 | $2.28M | Buy |
4,120
+33
| +0.8% | +$18.9K | 0.23% | 68 |
|
|
2024
Q1 | $2.38M | Sell |
4,087
-26
| -0.6% | -$14.6K | 0.24% | 71 |
|
|
2023
Q4 | $2.18M | Sell |
4,113
-134
| -3% | -$64.9K | 0.24% | 71 |
|
|
2023
Q3 | $2.15M | Buy |
4,247
+673
| +19% | +$359K | 0.25% | 70 |
|
|
2023
Q2 | $1.86M | Buy |
3,574
+309
| +9% | +$167K | 0.21% | 76 |
|
|
2023
Q1 | $1.88M | Buy |
3,265
+135
| +4% | +$76.1K | 0.22% | 76 |
|
|
2022
Q4 | $1.72M | Sell |
3,130
-14
| -0.4% | -$7.42K | 0.21% | 75 |
|
|
2022
Q3 | $1.59M | Buy |
3,144
+25
| +0.8% | +$14K | 0.21% | 73 |
|
|
2022
Q2 | $1.69M | Buy |
3,119
+95
| +3% | +$52.3K | 0.22% | 73 |
|
|
2022
Q1 | $1.79M | Buy |
3,024
+314
| +12% | +$180K | 0.2% | 76 |
|
|
2021
Q4 | $1.81M | Buy |
2,710
+1,205
| +80% | +$752K | 0.18% | 78 |
|
|
2021
Q3 | $860K | Buy |
1,505
+140
| +10% | +$76.8K | 0.1% | 95 |
|
|
2021
Q2 | $689K | Buy |
1,365
+23
| +2% | +$10.9K | 0.08% | 103 |
|
|
2021
Q1 | $612K | Buy |
1,342
+27
| +2% | +$12.9K | 0.07% | 101 |
|
|
2020
Q4 | $613K | Sell |
1,315
-14
| -1% | -$6.56K | 0.08% | 101 |
|
|
2020
Q3 | $587K | Hold |
1,329
| – | – | 0.08% | 99 |
|
|
2020
Q2 | $482K | Hold |
1,329
| – | – | 0.07% | 106 |
|
|
2020
Q1 | $377K | Hold |
1,329
| – | – | 0.06% | 114 |
|
|
2019
Q4 | $432K | Sell |
1,329
-20
| -1% | -$6.06K | 0.06% | 118 |
|
|
2019
Q3 | $393K | Hold |
1,349
| – | – | 0.06% | 121 |
|
|
2019
Q2 | $396K | Hold |
1,349
| – | – | 0.06% | 123 |
|
|
2019
Q1 | $369K | Buy |
1,349
+313
| +30% | +$77.9K | 0.06% | 126 |
|
|
2018
Q4 | $232K | Buy |
1,036
+130
| +14% | +$30.5K | 0.04% | 135 |
|
|
2018
Q3 | $221K | Buy |
+906
| New | +$208K | 0.03% | 149 |
|
Other funds holding TMO
Wendell David Associates's TMO Position: Q2 2026 in Review
Wendell David Associates reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $178K and leaving 2,087 shares worth $1.05M. The position accounts for 0.11% of the portfolio, ranked #91.
Wendell David Associates first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $2.66M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Wendell David Associates held 2,087 shares of Thermo Fisher Scientific worth $1.05M as of Q2 2026.
- Wendell David Associates sold 370 Thermo Fisher Scientific shares in Q2 2026, an estimated $178K.
- Thermo Fisher Scientific made up 0.11% of Wendell David Associates's portfolio in Q2 2026, its #91 holding.
- Wendell David Associates first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- Wendell David Associates's Thermo Fisher Scientific position peaked at $2.66M in Q3 2024.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.